Last reviewed · How we verify

NCT03511742

Functional ICUS in Uganda and Their Survival Outcomes

Status unknown Last updated 30 April 2018
What this trial tests

trial in Critical Illness in 367 participants. Status unknown.

Timeline
8 January 2018
Primary endpoint
30 April 2018
30 April 2018

Quick facts

Lead sponsorMakerere University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment367
Start date8 January 2018
Primary completion30 April 2018
Estimated completion30 April 2018
Sites1 location across Uganda

Conditions studied

Sponsor

Makerere University

Who can join

Eligibility, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is to describe the functional characteristics of Icus in Uganda and their @8-day patient characteristics it is a prospective cohort study .All Icus in Uganda will be included and their admitted patients followed upto 28 days in the ICU for mortality

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Characteristics and outcomes of patients admitted to intensive care units in Uganda: a descriptive nationwide multicentre prospective study.
    Atumanya P, Agaba PK, Mukisa J, Nakibuuka J, et al · · 2024 · cited 8× · PMID 38693185 · DOI 10.1038/s41598-024-59031-5

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Makerere University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03511742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing